METHODS OF PARKINSON'S DISEASE TREATMENT Russian patent published in 2009 - IPC A61K31/165 A61K31/198 A61K31/15 A61K31/195 A61K31/00 A61P25/16 A61K31/06 A61K31/13 A61K31/16

Abstract RU 2342929 C2

FIELD: medicine; pharmacology.

SUBSTANCE: are offered application of Safinamid from 0.5 to 1,2,3,4 or 5 mg/kg/day, in a combination with levodopa/PDI (peripheral antioxidant of decarboxylase: levodopa plus carbidopa (SINEMET®), levodopa plus carbidopa of controlled release (SINEMET-CR®), levodopa plus benserazide (MADOPAR®), levodopa plus benserazide of controlled release (MADOPAR-HBS) for treatment of Parkinson's disease, the corresponding set and the pharmaceutical composition.

EFFECT: additional effect of increase in frequency of revealing of the patients reacting to treatment with dopamine agonist.

8 cl, 2 tbl

Similar patents RU2342929C2

Title	Year	Author	Number
COMPOSITIONS FOR CONTINUOUS CONTROL OF DOPA-DECARBOXYLASE INHIBITORS	2010	Jakobi-Tseevi Oron Nemas Mara	RU2559083C9
COMPOSITIONS FOR CONTINUOUS ADMINISTRATION OF DOPA-DECARBOXYLASE INHIBITORS	2010	Yakobi-Tseevi Oron Nemas Mara	RU2678839C2
INTRODUCTION MODE FOR NITROCATECHOLS	2011	Soares Da Silva Patricio Manuel Vieira Araujo Nunes Teresal Lucia Silva Pereira Wright Lyndon Christopher Palma Pedro Nuno Leal Learmonth David Alexander	RU2639131C2
CONTINUOUS ADMINISTRATION OF L-DOPA, DOPA DECARBOXYLASE INHIBITORS, CATECHOL-METHYLTRANSFERASE INHIBITORS AND INTENDED FOR THIS COMPOSITION	2011	Yakobi-Tseevi Oron Nemas Mara	RU2740080C2
METHOD FOR TREATMENT OF PARKINSON'S DISEASE	2014	Yakobi-Tseevi Oron	RU2677278C2
α-AMINOAMIDE DERIVATIVES EFFECTIVE IN TREATING RESTLESS LEGS SYNDROME AND ADDICTIVE DISORDERS	2005	Bezana Klaudija Barbanti Elena Itstso Ehmanuela Taler Florian Far'Ello Rudzhero Sal'Vati Patrisija Benatti Luka	RU2403030C2
CONTINUOUS ADMINISTRATION OF L-DOPA, INHIBITORS OF DOPA-DECARBOXYLASE, INHIBITORS OF CATECHOL-O-METHYLTRANSFERASE AND COMPOSITIONS, INTENDED FOR IT	2011	Yakobi-Tseevi Oron Nemas Mara	RU2607497C2
PHARMACEUTICAL COMPOSITION IN FORM OF SINGLE ORAL DOSE CONTAINING LEVODOPA, CARBIDOPA AND ENTACAPONE, OR SALTS THEREOF	2009	Gupta Jatendra Kumar Dzhain Girish Kumar Talvar Munish Mashalkar Manodzh	RU2519159C2
NOVEL USING 2-[5-(4-FLUOROPHENYL)-3-PYRIDYLMETHYLAMINOMETHYL]-CHROMAN AND ITS PHYSIOLOGICALLY ACCEPTABLE SALTS	2002	Bartoshik Gerd Russ Germann Zejfrid Kristof Veber Frank	RU2297833C2
PHARMACEUTICAL COMPOSITION FOR TREATING, PREVENTING OR RELIEVING MOVEMENT DISORDERS AND ITS APPLICATION	2011	Khansen Dzhon Bondo Tomsen Mikel S.	RU2611376C2

RU 2 342 929 C2

Authors

Rudzhero Far'Ello

Kattaneo Karlo

Sal'Vati Patrisija

Benatti Luka

Dates

2009-01-10—Published

2004-04-08—Filed